Bruker

United States Founded: 1960 • Age: 66 yrs Listed
Diversified research instrument systems are manufactured and supplied.

About Bruker

Bruker is a publicly listed company based in United States founded in 1960. Diversified research instrument systems are manufactured and supplied. It operates on a Direct-to-Consumer (D2C) and Professional Services model in Healthcare and Technology sectors. The company has 11,400 employees. Bruker has completed 43 acquisitions, including ACQUIFER, Active Spectrum and Acuity Spatial Genomics. Its website bruker.com draws about 346 thousand monthly visits. Its Indian entity Bruker India Scientific Private Limited reported revenue of ₹165 Cr. Bruker offers products and services including Hysitron PI Envision SEM PicoIndenter, MOVE-T Liquid Dairy Analyzer, S8 TIGER Series 3, and nVista 2P System. Its focus areas include Life Sciences, Research Instruments, Scientific Instruments and Analytical Solutions. Its competitors include Cepheid, Beckman Coulter and Blackrock Neurotech; 2 of its 3 listed competitors have raised funding.

Company details

Innovative life science research and diagnostics solutions are delivered by Bruker. Focus is placed on spatial biology, single-cell analysis, and biopharma applications. Advanced instruments like NMR spectrometers and SEM nanoindentation systems are offered. Support is extended to academia and industry for scientific advancements. Services ensure maximized uptime and productivity for customers. Sectors such as healthcare, technology, and materials research are covered.

Key Metrics
  • Indian entity revenue
    ₹165 Cr

    FY 2025 · +2% YoY

  • Indian entity net profit
    ₹43.58 Cr

    FY 2025 · 26% margin

  • Indian entity EBITDA
    ₹61.78 Cr

    FY 2025 · 37% margin

  • Latest Funding Round
    $112.71K (USD), Grant

    Nov 2022

  • Investors
    HHS

    & 6 more

  • Employee Count
    11,400
  • Investments & Acquisitions
    ACQUIFER

    & 42 more

Products & Services of Bruker

Bruker offers a comprehensive portfolio of products and services, including Hysitron PI Envision SEM PicoIndenter, MOVE-T Liquid Dairy Analyzer, S8 TIGER Series 3, and nVista 2P System.

Hysitron PI Envision SEM PicoIndenter
Nanomechanical Testing

In-situ SEM nanoindentation system is used for testing.

MOVE-T Liquid Dairy Analyzer
Analytical Instruments

Compact FT-NIR analyzer is used for dairy analysis.

S8 TIGER Series 3
Elemental Analysis

Versatile tool is used for elemental industry analysis.

nVista 2P System
Neural Imaging

Two-photon miniscope is used for neural circuit imaging.

Apps and channels of Bruker

its YouTube channel Bruker has 3.54K subscribers and 30 videos.

Bruker
YouTube 3.54K subscribers 30 videos Science & Technology
Open channel

Videos from Bruker

The most watched videos on Bruker's YouTube channel, Bruker (3.54K subscribers). Click a video to play it here.

Graphite, Graphene, and Carbon Nanotube Analysis by Raman Microscopy and Imaging | RAMANtouch
822 views
POWER & VERSATILITY - D8 VENTURE
427 views
Electronics and PCB Failure Analysis | FT-IR Microscopy | LUMOS II | IEC 61191
252 views
Highlights from APNMR NMRS 2025 | IISER Pune
227 views

More on Bruker.

Funding Insights of Bruker

  • Total Rounds 41
  • Last Round Grant — $112,711
  • First Round $22.5M

    (Jan 2001)

  • Investors Count 7

Latest 10 of 41 funding rounds of Bruker with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Nov 2022$112,711Grant––
Sep 2022$29,972Grant––
Nov 2021$25,646Grant––
Oct 2021$103,069Grant––
Sep 2021$228,072Grant––
Dec 2020$34,021Grant––
Nov 2020$71,828Grant––
Oct 2020$1.16MGrant––
Mar 2020$1.63MGrant––
Jan 2020$14,180Grant––
Valuation history

7 investors in total: 7 institutional.

Investors in Bruker

Bruker has secured backing from 7 investors, including institutional investors. Prominent investors backing the company include HHS, European Commission and European Union.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
1958europa.euBrussels, Belgium
Institution of the European Union responsible for upholding the EU treaties
1958ec.europa.euBrussels, Belgium
Wealth management services are provided to high-net-worth clients.
1999tweisel.comSan Francisco, United States
Multi-category products are listed on an online B2B platform.
1994burrillandco.comWuxi, China
Provides investment strategies for growth and environmental sectors.
1976essexinvest.comBoston, United States
Scientific and technical information is managed and disseminated by OSTI.GOV.
osti.govOak Ridge, United States
Public health and human services are overseen by HHS.
1953hhs.gov
Premium access

Investor details for Bruker

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Board of directors of Bruker India Scientific Private Limited (Bruker)

Bruker India Scientific Private Limited is the primary company behind Bruker. The board of Bruker India Scientific Private Limited currently have 3 directors; the longest-serving is Ranjeet Kumar, appointed in 2014. 6 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Ranjeet Kumar
DIN 06938464
Director01 Sep 201412 yrs 2 moBruker India Scientific Private Limited
Rosa Leng Hong Tan
DIN 06941651
Director01 Sep 201412 yrs 2 moBruker India Scientific Private Limited
Arin Kumar Chakraborti
DIN 00402560
Alternate Director15 Sep 20206 yrs 2 moBruker India Scientific Private Limited

People of Bruker

243 people are tracked at Bruker (75 in leadership, 10 in board & advisors, 158 in team); the tracked headcount is 11,400.

NameRoleGroup
Falko Busse
President, Bruker BioSpin GroupLeadership
Christian Schürr
Head Of Factory And R&d ControllingLeadership
Frank Laukien
Chairman, President & CEOLeadership
Angela Mazzonetto
Chief Privacy OfficerLeadership
Juergen Srega
President, Bruker CALID GroupLeadership
Mark R. Munch
EVP & President, Bruker Nano Group & Bruker Nano Surfaces DivisionLeadership
Gerald N. Herman
EVP & Chief Financial OfficerLeadership
Barbara Burgess
Vice President, Financial Operations & Project ManagementLeadership
Beata Adamczyk
Principal Finance Business PartnerLeadership
Klaus Schlenga
Executive Vice President & CTO Bruker ESTLeadership
Mark McMaster
Executive Vice President Of Operations, Bnano Group And Bruker Nano Surfaces DivisionLeadership
Niels Grote
Head Of Salesforce Competence CenterLeadership
Matthias Boese
Vice President Compact Systems, Microscopy & Life ScienceLeadership
Daniel Hornburg
Vice President Biomarkers & Precision MedicineLeadership
Bjorn Johnson
Senior Vice President, Legal, And General Counsel, Bruker Nano GroupLeadership
Kora Knuchel
Vice President, IP And Legal (lsms)Leadership
Shanil Govindpershad
Managing Director & GM Of Bruker SA (pty) Ltd & Head Of Commercial Operations For AfricaLeadership
Jeffrey Zonderman
Senior Vice PresidentLeadership
Phil Simmons
Vice President, Global SalesLeadership
Erica Forsberg
Vice President MetabolomicsLeadership

223 more people are available in the full profile.

Premium access

Complete people profiles for Bruker

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

IPO & Listings of Bruker

Bruker is a publicly listed company on the NASDAQ with ticker symbol BRKR in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

  • IPO date04 Aug 2000
  • Listed onNASDAQ: BRKR
  • Listed entityBruker Corporation
  • Exchange sectorHealth technology
  • ISINUS1167941087
  • Share price$56.19 (-0.11% on the day) · 2026-10-13
  • Market capitalisation$8.56B
  • EPS (diluted, trailing year)$-0.70
  • Dividend yield0.36%
  • Volume (last session)2,171,863

Financials of Bruker

Figures of Bruker India Scientific Private Limited, the primary company behind Bruker, for FY 2025. Revenue was ₹165 Cr (+2% year on year). Net profit was ₹43.58 Cr (26% margin). EBITDA was ₹61.78 Cr (37% margin). Revenue has grown at a compounded annual rate of +20% over three years and +11% over five years.

  • ₹165 CrRevenue · FY 2025 · +2% YoY
  • ₹43.58 CrNet profit · 26% margin
  • ₹61.78 CrEBITDA · 37% margin
  • ₹1.9 LakhPaid-up capital
  • 132Employees (provident fund records)
  • +20%Revenue CAGR, 3 years
  • +11%Revenue CAGR, 5 years
Exchange-reported annual figures
YearRevenueNet incomeEBITDA
2025$3.44B-$8.6M$500.5M
2024$3.37B$113.1M$563.6M
2023$2.96B$427.2M$597.2M
2022$2.53B$296.6M$548.3M
2021$2.42B$277.1M$517.4M

Balance sheet, profit and loss, cash flow and ratios of Bruker India Scientific Private Limited are on its company page.

Premium access

Detailed financial statements for Bruker

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Bruker

Bruker has strategically engaged in corporate development activities, having acquired 43 companies. Notable acquisitions include ACQUIFER, Active Spectrum and Acuity Spatial Genomics.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Targeted metabolic phenotyping kits are developed for research and diagnostics.
biocrates.comInnsbruck, Austria2002Jun 2025••••
RECIPE is engaged in clinical diagnostics with HPLC and LC-MS/MS solutions.
recipe.deGermany0Apr 2025••••
Label-free solutions for molecular interactions and biophysical analysis are provided.
dynamic-biosensors.comPlanegg, Germany2011Oct 2024••••
Tools for translational research and molecular diagnosis are developed.
nanostring.comSeattle, United States2003Apr 2024$392.6M
Raman microscopy equipment is developed for material analysis.
nanophoton.netOsaka, Japan2003Feb 2024••••
Image analysis software is provided for medical professionals.
spectralinvivo.comTucson, United States1993Feb 2024••••
Lab automation solutions are manufactured for R&D laboratories.
chemspeed.comFullinsdorf, Switzerland1997Jan 2024••••
Manufacturer of optical spectroscopy instruments using Raman spectroscopy
tornado-spectral.comToronto, Canada2013Jan 2024••••
Advanced scanning transmission electron microscopes and electron-optical instruments are developed.
nion.comKirkland, United States1997Jan 2024••••
Diagnostic instrumentation and assays
elitechgroup.comPuteaux, France1987Dec 2023$943.91M
Premium access

Complete acquisition details for Bruker

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of Bruker

14 dated milestones of Bruker across 65 years, from founding to its latest funding, stage changes and deals.

  1. Founded Bruker is founded.
  2. IPO Lists on the stock exchange (IPO).
  3. Funding First funding round of $22.5M.
  4. Funding Latest funding round, Grant, of $113K.
  5. Acquisition Acquires ElitechGroup.
  6. Acquisition Acquires Bruker.
  7. Acquisition Acquires Tornado Spectral Systems.
  8. Acquisition Acquires Chemspeed.
  9. Acquisition Acquires Spectral Instruments Imaging.
  10. Acquisition Acquires Nanophoton.
  11. Acquisition Acquires NanoString.
  12. Acquisition Acquires Dynamic Biosensors.
  13. Acquisition Acquires RECIPE.
  14. Acquisition Acquires Biocrates.

Competitors of Bruker

Bruker has 3 listed competitors in our database, 2 of them funded. They include Cepheid, Beckman Coulter and Blackrock Neurotech.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
cepheid.com1996Sunnyvale, United States$19.1M1,299
Developer of molecular diagnostic testing solutions
beckman.com1935Brea, United States
Provider of products for biomedical testing for R&D, diagnostic and commercial applications
blackrockneurotech.com2008Salt Lake, United States$22.37M127
Medical devices for neurological therapies are developed.
Premium access

Detailed competitors of Bruker

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Bruker

The website of Bruker (bruker.com) receives about 346K visits a month and ranks #136,650 among all websites worldwide, #8,791 in Chemistry.

  • Monthly visits
    346K

    ▲ 1.5% vs previous month

  • Unique visitors
    160.1K

    per month

  • Global rank
    #136,650

    among all websites

  • Category rank
    #8,791

    Science and Education · Chemistry

Similar websites

Websites whose visitors overlap most with Bruker. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
waters.com
100%
416.8K#124,184View details
bmrb.wisc.edu
bmrb.wisc.edu
98%
–
malvernpanalytical.com
83%
211.4K#212,867View details
tecmag.com
78%
1K#14,672,646View details
parkafm.com
parkafm.com
76%
–
••••••••••••••••.com••%•.•M#•••••–
••••••••••••••••.com••%•.•M#•••••–
••••••••••••••••.com••%•.•M#•••••–
Premium access

All 40 similar websites and full traffic analytics for Bruker

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 40 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Top companies in Life Sciences Platforms & Tools

3 companies that operate in the same segment as Bruker (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Medidata is recognized as a leading provider of SaaS solutions for clinical research.
1999New York, New York, United StatesUSD 41.5 M
AI-based solutions for health management are provided.
2015Dallas, Texas, United StatesUSD 2.8 B1,111
Real-world health data is provided for research and decisions.
2012Menlo Park, California, United StatesUSD 259.16 M
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Bruker

Premium access

Complete news archive for Bruker

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Bruker

Bruker was founded in 1960 and raised its 1st funding round 41 years after it was founded.

Bruker is headquartered in United States.

Bruker has 11,400 employees.

The primary company behind Bruker, Bruker India Scientific Private Limited, reported revenue of ₹165 Cr for FY 2025, up 2% year on year.

Innovative life science research and diagnostics solutions are delivered by Bruker. Focus is placed on spatial biology, single-cell analysis, and biopharma applications. Advanced instruments like NMR spectrometers and SEM nanoindentation systems are offered. Support is extended to academia and industry for scientific advancements. Services ensure maximized uptime and productivity for customers. Sectors such as healthcare, technology, and materials research are covered.

Bruker's top competitors include Cepheid, Blackrock Neurotech and Beckman Coulter.

Bruker offers Hysitron PI Envision SEM PicoIndenter, MOVE-T Liquid Dairy Analyzer, S8 TIGER Series 3, and nVista 2P System.

Yes, Bruker is publicly traded on NASDAQ under the ticker symbol BRKR.

Bruker has made 43 acquisitions, including ACQUIFER, Active Spectrum, and Acuity Spatial Genomics.

Bruker has 7 investors. Key investors include HHS, European Commission, European Union, Burrill and Company, and Thomas Weisel Partners.

Bruker operates through Bruker India Scientific Private Limited.

The legal entities of Bruker currently have 3 directors, including Ranjeet Kumar, Rosa Leng Hong Tan, Arin Kumar Chakraborti.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available